Bicycle Therapeutics Plc - ADR


Market Cap$510.89M

Compare Bicycle Therapeutics Plc - ADR

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Bicycle Therapeutics Plc - ADRBicycle Therapeutics Plc - ADR-2.80%-49%24.60.1
marketMarket Avg49.61.28%30%6.11.1
HealthcareHealthcare Avg32.71.25%19%7.40.9

Current Fair Value

71% upside

Undervalued by 71% based on the discounted cash flow analysis.

Share Statistics

Market cap$510.89 Million
Enterprise Value$24.55 Million
Dividend Yield$0.0 (0.0%)
Earnings per Share$-5.08
Outstanding Shares21,304,801
Avg 30 Day Volume394,759


Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio-2.83
Price to Sales24.64
Price to Book Ratio1.45
Enterprise Value to Revenue0.91
Enterprise Value to EBIT-0.13
Enterprise Value to Net Income-1
Total Debt to Enterprise1.63
Debt to Equity0.11

Revenue Sources

No data

ESG Score

No data

About Bicycle Therapeutics Plc

CEO: Kevin Lee